Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation.
about
Caveolin-1 associates with TRAF2 to form a complex that is recruited to tumor necrosis factor receptorsAntitumor necrosis factor therapy for inflammatory bowel disease: a review of agents, pharmacology, clinical results, and safety.TNF ligands and receptors--a matter of life and death.Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects.Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75Myxoma virus T2 protein, a tumor necrosis factor (TNF) receptor homolog, is secreted as a monomer and dimer that each bind rabbit TNFalpha, but the dimer is a more potent TNF inhibitor.TNF-α-induced programmed cell death in the pathogenesis of acquired aplastic anemia.Tumour necrosis factor-alpha (TNF-alpha): the good, the bad and potentially very effective.Biochemical characterization of the molecular interaction between recombinant basic fibroblast growth factor and a recombinant soluble fibroblast growth factor receptor.Soluble receptors and cytokine antagonists in human milk.Soluble tumor necrosis factor-alpha (TNF-alpha) receptors in human colostrum and milk bind to TNF-alpha and neutralize TNF-alpha bioactivity.Effects of propyl gallate on interaction between TNF-alpha and sTNFR-I using an affinity biosensor.Generation and biological characterization of membrane-bound, uncleavable murine tumor necrosis factor.Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies.Mechanisms of Fish Macrophage Antimicrobial Immunity.
P2860
Q28139933-9CBA3121-1215-41FB-A209-58416E86963BQ33641577-C8E56EE5-3014-49F3-B7EE-91B2178B8B9CQ34542205-5685EC6C-6A64-46AE-B9A7-3C4B41D96C0FQ36266899-E7F2248C-4AE1-4B0A-A402-C0F475BADB07Q36364423-F88569A5-0430-423B-9A12-D4D280063C56Q38356806-EA34CA34-BBD1-4276-86A7-5E046EEB9B76Q38543416-A11714A0-F87C-423F-8D37-772ADB7DBC72Q41205458-46234B29-BF3B-4820-AFA5-29BC1CB49EC6Q42140621-EB3C2E9B-3D62-439A-9649-95F877000DE8Q45101752-AFE3CB2B-F33F-43E2-A513-2B22B6D2460AQ45112568-4C0C2F01-51BA-4C10-B4F4-4757D0CC7278Q46713144-E1CAD7F8-AC4A-4FC7-A698-B04B84DDE541Q49167564-34D9F3B3-63BB-4565-85DD-060BBE81C419Q54941559-E7A79DD0-8F16-4759-B66D-761CDD2FF668Q55014189-6D88420F-C407-41A1-AC5F-09750304D730
P2860
Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
Characterization of a recombin ...... induced receptor aggregation.
@en
type
label
Characterization of a recombin ...... induced receptor aggregation.
@en
prefLabel
Characterization of a recombin ...... induced receptor aggregation.
@en
P2093
P356
P1433
P1476
Characterization of a recombin ...... induced receptor aggregation.
@en
P2093
Borchardt PE
Goeddel DV
P304
P356
10.1021/BI00119A023
P407
P577
1992-02-01T00:00:00Z